153 related articles for article (PubMed ID: 12973749)
1. Treating the full spectrum of dementia with memantine.
Winblad B; Jelic V
Int J Geriatr Psychiatry; 2003 Sep; 18(Suppl 1):S41-6. PubMed ID: 12973749
[TBL] [Abstract][Full Text] [Related]
2. [Advanced dementia in Alzheimer's disease and memantine].
Alberca R
Rev Neurol; 2005 Feb 1-15; 40(3):173-9. PubMed ID: 15750904
[TBL] [Abstract][Full Text] [Related]
3. [Glutamate-related excitotoxicity neuroprotection with memantine, an uncompetitive antagonist of NMDA-glutamate receptor, in Alzheimer's disease and vascular dementia].
Tanović A; Alfaro V
Rev Neurol; 2006 May 16-31; 42(10):607-16. PubMed ID: 16703529
[TBL] [Abstract][Full Text] [Related]
4. Memantine: update on the current evidence.
Möbius HJ
Int J Geriatr Psychiatry; 2003 Sep; 18(Suppl 1):S47-54. PubMed ID: 12973750
[TBL] [Abstract][Full Text] [Related]
5. Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies.
Tariot PN
J Clin Psychiatry; 2006; 67 Suppl 3():15-22; quiz 23. PubMed ID: 16649847
[TBL] [Abstract][Full Text] [Related]
6. Memantine for dementia?
Drug Ther Bull; 2003 Oct; 41(10):73-6. PubMed ID: 14593973
[TBL] [Abstract][Full Text] [Related]
7. Memantine: pharmacological properties and clinical uses.
Kumar S
Neurol India; 2004 Sep; 52(3):307-9. PubMed ID: 15472417
[TBL] [Abstract][Full Text] [Related]
8. Drug therapy of dementia in elderly patients. A review.
Olsen CE; Poulsen HD; Lublin HK
Nord J Psychiatry; 2005; 59(2):71-7. PubMed ID: 16195103
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy of memantine in the treatment of Alzheimer's disease].
Molinuevo Guix JL; Lladó Plarrumaní A
Neurologia; 2005 Dec; 20(10):686-91. PubMed ID: 16317590
[TBL] [Abstract][Full Text] [Related]
10. Magnesium supplementation in the treatment of dementia patients.
Ozturk S; Cillier AE
Med Hypotheses; 2006; 67(5):1223-5. PubMed ID: 16790324
[TBL] [Abstract][Full Text] [Related]
11. [The action of memantine on the cognitive disorders of patients with dementia: reflections following two years' experience in Spain].
Robles-Bayón A
Rev Neurol; 2006 Mar 1-15; 42(5):288-96. PubMed ID: 16538592
[TBL] [Abstract][Full Text] [Related]
12. Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists.
Muir KW
Curr Opin Pharmacol; 2006 Feb; 6(1):53-60. PubMed ID: 16359918
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of degenerative dementia disorders--who should be treated?].
Hasselbalch SG; Kampmann JP
Ugeskr Laeger; 2009 Mar; 171(10):802-5. PubMed ID: 19265606
[TBL] [Abstract][Full Text] [Related]
14. When should drug treatment be started for people with dementia?
Singh B; O'Brien JT
Maturitas; 2009 Mar; 62(3):230-4. PubMed ID: 19201114
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the effect of memantine in reducing the worsening of clinical symptoms in patients with moderate to severe Alzheimer's disease.
Wilkinson D; Andersen HF
Dement Geriatr Cogn Disord; 2007; 24(2):138-45. PubMed ID: 17622761
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of memantine in moderate-to-severe Alzheimer disease: the evidence to date.
Bullock R
Alzheimer Dis Assoc Disord; 2006; 20(1):23-9. PubMed ID: 16493232
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotection in vascular dementia.
Martínez-Vila E; Murie-Fernández M; Gállego Pérez-Larraya J; Irimia P
Cerebrovasc Dis; 2006; 21 Suppl 2():106-17. PubMed ID: 16651821
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease and the glutamate NMDA receptor.
Doraiswamy PM
Psychopharmacol Bull; 2003; 37(2):41-9. PubMed ID: 14566213
[TBL] [Abstract][Full Text] [Related]
19. Memantine enhances autonomy in moderate to severe Alzheimer's disease.
Rive B; Vercelletto M; Damier FD; Cochran J; François C
Int J Geriatr Psychiatry; 2004 May; 19(5):458-64. PubMed ID: 15156547
[TBL] [Abstract][Full Text] [Related]
20. [The clinical relevance of memantine use].
Sobów T
Psychiatr Pol; 2004; 38(2):321-30. PubMed ID: 15307296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
